Use of etherlysophospholipids as antiinflammatory agents

Details Use of etherlysophospholipids as antiinflammatory agents Use of etherlysophospholipids as antiinflammatory agents

A - Human Necessities

61

K

A61K 31/66 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2356736

The present invention relates to the use of a series of etherlysophospholipids (ELPs) for the preparation of a medicament for the treatment of an inflammatory disease without causing adverse gastrointestinal side effects and/or without inhibition of phospholipase A2 and prostaglandin E2, as well as preventing or treating ulcerative conditions of the gastrointestinal tract.

La présente invention concerne l'utilisation d'une série d'étherlysophospholipides pour préparer un médicament destiné au traitement d'une maladie inflammatoire sans produire d'effets secondaires néfastes au niveau gastro-intestinal et/ou sans inhiber la phospholipase A¿2? et la prostaglandine E¿2?, ainsi que pour prévenir ou traiter les états ulcéreux du tractus gastro-intestinal.

Affiliated with

Also associated with

Rating

Use of etherlysophospholipids as antiinflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of etherlysophospholipids as antiinflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of etherlysophospholipids as antiinflammatory agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1588576